The role of estrogen in bipolar disorder, a review

Nordic Journal of Psychiatry

Volumn 68, Issue 2, 2014, Pages 81-87

  Meinhard, Ninja ^a   Kessing, Lars Vedel ^a   Vinberg, Maj ^a  

^a University of Copenhagen   (Denmark)

Author keywords

Bipolar disorder; Estrogen; Mania; Tamoxifen

Indexed keywords

CHLORPROMAZINE; ESTRADIOL; ESTROGEN; LITHIUM; LUTEINIZING HORMONE; PROGESTERONE; TAMOXIFEN; VALPROIC ACID;

AUDITORY HALLUCINATION; BIPOLAR DISORDER; CHILDBIRTH; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; HUMAN; PARANOIA; PSYCHOSIS; PUERPERAL PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; ESTROGENS; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PUERPERAL DISORDERS; TAMOXIFEN;

EID: 84893113901     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2013.775341     Document Type: Review

References (27)

1. Kulkarni J, Garland KA, Scaffi di A, Headey B, Anderson R, de Castella A, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology. 2006; 31: 543 - 7.
2. Zarate CA Jr, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, et al. Effi cacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: A pilot study. Bipolar Disord 2007; 9: 561 - 70.
3. Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, et al. Gender differences in bipolar disorder: Age of onset, course, comorbidity, and symptom presentation. Bipolar Disord 2005; 7: 119 - 25.
4. Difl orio A, Jones I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010; 22: 437 - 52.
5. Payne JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry 2003; 15: 280 - 90.
6. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8 - 19.
7. Kessing LV. Gender differences in the phenomenology of bipolar disorder. Bipolar Disord 2004; 6: 421 - 5.
8. Kessing LV. The prevalence of mixed episodes during the course of illness in bipolar disorder. Acta Psychiatr Scand 2008; 117: 216 - 24.
9. Baldassano CF, Marangell LB, Gyulai L, Ghaemi SN, Joffe H, Kim DR, et al. Gender differences in bipolar disorder: Retrospective data from the fi rst 500 STEP-BD participants. Bipolar Disord. 2005; 7: 465 - 70.
10. Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: A population-based register study. JAMA 2006; 296: 2582 - 9.
11. Douma SL, Husband C, O' Donnell ME, Barwin BN, Woodend AK. Estrogen-related mood disorders: Reproductive life cycle factors. ANS Adv Nurs Sci 2005; 28: 364 - 75.
12. Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. BMJ 1991; 303: 613 - 6.
13. Wieck A, Davies RA, Hirst AD, Brown N, Papadopoulos A, Marks MN, et al. Menstrual cycle effects on hypothalamic dopamine receptor function in women with a history of puerperal bipolar disorder. J Psychopharmacol 2003; 17: 204 - 9.
14. Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF. Protein kinase C inhibition in the treatment of mania: A doubleblind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008; 65: 255 - 63.
15. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, et al. Double-blind, randomized, placebocontrolled 6-week study on the effi cacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2011; 129: 327 - 31.
16. Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol 2012 Oct 4.
17. O' Regan RM, Jordan VC. The evolution of tamoxifen therapy in breast cancer: Selective oestrogen-receptor modulators and downregulators. Lancet Oncol 2002; 3: 207 - 14.
18. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992; 326: 852 - 6.
19. Cyr M, Landry M, Di Paolo T. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 2000; 23: 69 - 78.
20. Ahokas A, Aito M. Role of estradiol in puerperal psychosis. Psychopharmacology 1999; 147: 108 - 10.
21. Ahokas A, Aito M, Rimó n R. Positive treatment effect of estradiol in postpartum psychosis: A pilot study. J Clin Psychiatry 2000; 61: 166 - 9.
22. Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressicve episodes during the menopausal transition in women with bipolar disorder: Preliminary report. Psychiatr Res 2008; 42: 247 - 51.
23. Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll- Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipol Disord 2012; 14: 515 - 26. DOI: 10.1111/j.1399-5618.2012.01026.x.
24. Kessing LV, Søndergård L, Kvist K, Andersen PK. Adherence to lithium in naturalistic settings: Results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007; 9: 730 - 6.
25. Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, et al. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: Comparison between tamoxifen-treated and nontreated breast cancer patients. Gynecol Oncol 1999; 72: 202 - 7.
26. Willcox DL, Yovich JL, McColm SC, Phillips JM. Progesterone, cortisol and oestradiol-17 beta in the initiation of human parturition: Partitioning between free and bound hormone in plasma. Br J Obstet Gynaecol. 1985; 92: 65 - 71.
27. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, et al. For the Women' s Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004; 292: 1573 - 1580.